QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial

Compugen (CGEN) Earnings Date, Estimates & Call Transcripts

→ The #1 Opportunity of the decade? (From Behind the Markets) (Ad)
Free CGEN Stock Alerts
$1.90
+0.02 (+1.06%)
(As of 04:20 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 20Estimated
Actual EPS
(Mar. 5)
$0.11 Beat By $0.01
Consensus EPS
(Mar. 5)
$0.10
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

CGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Compugen Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.12)($0.08)($0.10)
Q2 20242($0.12)($0.08)($0.10)
Q3 20242($0.13)($0.08)($0.11)
Q4 20242($0.29)($0.13)($0.21)
FY 20248($0.66)($0.37)($0.52)

CGEN Earnings Date and Information

Compugen last issued its quarterly earnings data on March 5th, 2024. The biotechnology company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. The business had revenue of $33.46 million for the quarter, compared to analyst estimates of $60 million. Compugen has generated ($0.22) earnings per share over the last year (($0.22) diluted earnings per share). Earnings for Compugen are expected to decrease in the coming year, from $0.02 to ($0.27) per share. Compugen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Compugen Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)		------- 
3/5/2024Q4 2023$0.10$0.11+$0.01$0.11$60.00 million$33.46 million
11/7/2023Q3 2023($0.09)($0.11)($0.02)($0.11)--
8/7/2023Q2 2023($0.13)($0.11)+$0.02($0.11)--    
5/15/2023Q1 2023($0.12)($0.11)+$0.01($0.11)--  
2/27/2023Q4 2022($0.14)($0.04)+$0.10($0.04)-$7.50 million    
11/14/2022Q3 2022($0.13)($0.14)($0.01)($0.14)--
8/4/2022Q2 2022($0.12)($0.11)+$0.01($0.11)--    
5/16/2022Q1 2022($0.12)($0.11)+$0.01($0.11)--
2/24/2022Q4 2021($0.15)($0.10)+$0.05($0.10)$0.86 million-    
11/12/2021Q3 2021($0.13)($0.07)+$0.06($0.07)-$6.00 million    
7/28/2021Q2 2021($0.12)($0.11)+$0.01($0.11)--    
5/13/2021Q1 2021($0.13)($0.12)+$0.01($0.12)--  

Compugen Earnings - Frequently Asked Questions

When is Compugen's earnings date?

Compugen has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on CGEN's earnings history.

Did Compugen beat their earnings estimates last quarter?

In the previous quarter, Compugen (NASDAQ:CGEN) reported $0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $0.10 by $0.01. Learn more on analysts' earnings estimate vs. CGEN's actual earnings.

How much revenue does Compugen generate each year?

Compugen (NASDAQ:CGEN) has a recorded annual revenue of $33.46 million.

How much profit does Compugen generate each year?

Compugen (NASDAQ:CGEN) has a recorded net income of -$18.75 million. CGEN has generated -$0.22 earnings per share over the last four quarters.

What is Compugen's EPS forecast for next year?

Compugen's earnings are expected to decrease from $0.02 per share to ($0.27) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:CGEN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative